Related Experiment Video
Updated: Sep 12, 2026

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
Posterior Reversible Encephalopathy Syndrome Associated With Severe Proton Pump Inhibitor-Induced Hypomagnesemia: A
Clotilde Ciampa1, Antonella Antenora1, Ciro Salzano2
1Neurology, San Giovanni Bosco Hospital, Local Health Authority (ASL) Napoli 1 Centro, Naples, ITA.
Abstract:
Posterior reversible encephalopathy syndrome (PRES) is a potentially reversible cause of acute neurological deterioration. Hypertension is the most common trigger, but metabolic and drug-related causes must also be considered. We describe a patient who developed PRES with posterior circulation involvement in the absence of hypertension. The patient showed severe hypomagnesemia after prolonged proton pump inhibitor (PPI) use, where the onset of neurological symptoms occurred after the increase of esomeprazole (40 mg/day). Brain magnetic resonance imaging (MRI) showed PRES findings in the cerebellum, evolving into a gliotic lesion. Hypomagnesemia may promote endothelial dysfunction and vasogenic edema and has been increasingly linked to PRES. In patients with PRES and no clear trigger, serum magnesium should be monitored, especially in long-term PPI users. This case highlights a reversible and preventable cause of PRES, supporting the need to monitor serum magnesium and prescribe PPIs with caution in clinical practice.
Related Concept Videos
Hepatic Encephalopathy
Encephalitis l: Introduction
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Antiepileptic Drugs: Glutamate Antagonists
Cerebral Edema ll: Pathophysiology
Rocky Mountain Spotted Fever
